Free Trial

Gracell Biotechnologies (GRCL) Earnings Date, Estimates & Call Transcripts

Notice: This company has been marked as potentially delisted and may not be actively trading.
Skip Charts & View Estimated and Actual Earnings Data

GRCL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GRCL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Gracell Biotechnologies Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.92) EPS
Next Year EPS Consensus Estimate: ($0.97) EPS

Gracell Biotechnologies Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/13/2023Q3 2023($0.26)($0.10)+$0.16($0.10)--
8/14/2023Q2 2023($0.37)($0.30)+$0.07($0.30)--
5/15/2023Q1 2023($0.35)($0.35)-($0.35)--
3/13/2023Q4 2022($0.43)($0.30)+$0.13($0.30)--    
11/14/2022Q3 2022($0.09)($0.36)($0.27)($0.36)--    
8/15/2022Q2 2022($0.08)($0.32)($0.24)($0.32)--    
5/16/2022Q1 2022($0.08)($0.37)($0.29)($0.37)--    
3/14/2022Q4 2021($0.38)($0.30)+$0.08($0.30)--    
11/14/2021Q3($0.12)($0.30)($0.18)($0.06)-$0.06 million
8/16/2021Q2 2021($0.12)($0.20)($0.08)($0.22)--    
5/16/2021Q1($0.2130)($0.25)($0.0370)($0.25)--
3/8/2021Q4($0.27)($0.16)+$0.11---  

Gracell Biotechnologies Earnings - Frequently Asked Questions

How much revenue does Gracell Biotechnologies generate each year?

Gracell Biotechnologies (NASDAQ:GRCL) has a recorded annual revenue of $60,000.00.

How much profit does Gracell Biotechnologies generate each year?

Gracell Biotechnologies (NASDAQ:GRCL) has a recorded net income of -$88.08 million. GRCL has generated -$1.05 earnings per share over the last four quarters.

What is Gracell Biotechnologies's EPS forecast for next year?

Gracell Biotechnologies's earnings are expected to decrease from ($0.92) per share to ($0.97) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:GRCL) was last updated on 6/19/2024 by MarketBeat.com Staff

From Our Partners